Impact of CYP2C9‐Interacting Drugs on Warfarin PharmacogenomicsSaaket Agrawal, Alfred L. George, Meredith S. Heiss et al.|Clinical and Translational Science|2020Cited by 20
Multiple myeloma with extramedullary plasmacytoma: pathogenesis and clinical caseМ. В. Фирсова, Л. П. Менделеева, Natalya Risinskaya et al.|Oncohematology|2022Cited by 8
Prognostic value of 1q21 amplification in multiple myelomaTatiana Abramova, Savchenko Vg, В В Рыжко et al.|Terapevticheskii arkhiv|2017Cited by 4
MOLECULAR GENETIC STRUCTURE OF MULTIPLE MYELOMA TUMOUR CELLS PRIOR TO TREATMENT AND AT THE TIME OF RELAPSE: SHORT REVIEW AND CASE REPORTAnna Sergeeva, Л. П. Менделеева, Tatiana Abramova et al.|Гематология и трансфузиология|2019Cited by 2
Structure and signifi cance of cytogenetic abnormalities in patients with multiple myelomaTatiana Abramova, Л. П. Менделеева, Т. Н. Обухова et al.|Гематология и трансфузиология|2021Cited by 2